Definitive Contract HDTRA120C0016
Award Date
6/15/20
Potential Completion Date
1/14/25
Potential Value
$1.2M
Federal Agency
Defense Threat Reduction Agency
Awardee
Ministry Of Defence
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
152
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,994,572.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract is for the generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague. This contract is not set aside. DSTL has secured multiple high-value federal contracts from DTRA...
This is a $523,200.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), located in the United Kingdom. The contract is for basic research to support DTRA and Department of Homeland Security efforts to counter chemical, biological, radiological, and nuclear threats. Past MOD contracts have included developing medical countermeasures, diagnostic...
This is a $3,947,011.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The contract is for a research and development effort focused on using virus-like particles as a novel platform for delivering protective antigens against Burkholderia bacteria. The contract does not have a set-aside designation. DSTL is a...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract...
This is a $2,758,080.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (doing business as D S T L), a United Kingdom government entity. The contract is for the project "HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)" and has a March 30, 2023 completion date. The contract was awarded on December 10, 2018 and was not set aside for any special designation. D S T L, as a foreign government...
This is a $6,400,448.87 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence's Defence Science and Technology Laboratory (D S T L), a United Kingdom government entity, to develop non-ionic surfactant vesicles (NISVS) as a drug delivery and targeting system for antimicrobials. The contract has no set-aside designation and represents a continuation of DTRA's ongoing extramural research and development efforts focused on countering...
This is a $5,570,766.33 delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to the UK Health Security Agency, formerly known as Public Health England. The contract is for biological animal model and medical countermeasure development services to support the Biomedical Advanced Research and Development Authority's (BARDA) efforts to combat chemical, biological, radiological, and nuclear threats....
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Dublin City University, a non-profit organization located in Ireland. The contract, which does not have a set-aside designation, is a definitive contract with a cost-no-fee pricing type. The contract was awarded on April 2, 2007 with a ceiling value of $3,715,224.19 and an ultimate completion date of April 1, 2011. The contract is for the "BASE YEAR" of performance. Without additional...
This is a $5,162,303.00 Firm Fixed Price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Hvivo Services LIMITED, a foreign-owned for-profit organization, for research and development in accordance with the statement of work entitled "First Influenza Recognition and Elucidation". The contract was awarded on September 8, 2017, with a completion date of July 26, 2019, and does not have a set-aside designation. The place of performance is Great...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Sanofi Pasteur Vaxdesign Corp, a for-profit foreign-owned organization. The contract is a Cost Plus Fixed Fee Definitive Contract with a ceiling value of $10,779,939.95 and an ultimate completion date of March 24, 2018. The contract was awarded on March 21, 2013 and does not have a set-aside designation. The contract is for the BASE YEAR, indicating it may be part of a larger contract...